3651 results for «301»

Filter By

3651 results

PCR's Got Talent - Round 2 - Session 1

15 May 2024 – From EuroPCR 2024

PCR's Got Talent - Round 2 - Session 1

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

PCR's Got Talent - Round 2 - Session 2

15 May 2024 – From EuroPCR 2024

This session features a selected abstract submission from EuroPCR 2024 on plaque characterization, outcomes, and predictors of recurrent events in stent failure, as studied using optical coherence tomography (OCT).

PCR's Got Talent - Round 2 - Session 2

TEER for primary mitral regurgitation - LIVE case

15 May 2024 – From EuroPCR 2024

A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...

Mitral TEER

Valve-in-valve: utility of splitting devices

15 May 2024 – From EuroPCR 2024

This session focuses on the use of specialized splitting devices for transcatheter aortic valve-in-valve procedures. It features a case series demonstrating the application of a dedicated splitting device in failed TAVI valves, as well as the use of the BASILICA technique for transcatheter aortic valve replacement....

Valve-in-valve: utility of splitting devices

Devices in pulmonary embolism - Why you should be interested!

15 May 2024 – From EuroPCR 2024

This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...

Devices in pulmonary embolism - Why you should be interested!

Management of patient with coronary artery disease and left ventricle dysfunction

15 May 2024 – From EuroPCR 2024

This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...

Management of patient with coronary artery disease and left ventricle dysfunction

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy

17 Sep 2022

Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.

Alessandro Sticchi

Author

Alessandro Sticchi
The PASCAL IID Registry: A Prospective Registry for Transcatheter Edge-to-Edge Repair in Prohibitive Risk Patients With Degenerative MR and Complex Mitral Valve Anatomy

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?